Business Wire

IFF Appoints Dawn Willoughby to Board of Directors

Share

IFF (NYSE: IFF) today announced the appointment of accomplished consumer products industry executive Dawn Willoughby to the Company’s Board of Directors as an independent director, effective Feb. 1, 2023. Willoughby, who most recently served as executive vice president and chief operating officer of The Clorox Company, brings an impressive track record of driving sustainable, profitable growth with a focus on innovation and sustainability for global consumer businesses.

“We are thrilled to welcome Dawn to the IFF Board as we continue to evolve our Board consistent with the plans announced in our December Investor Day, and prioritize the addition of senior executives with the most relevant skills, leadership experience and business expertise needed to support our company’s continued growth and transformation,” said Dale Morrison, chair of IFF’s Board of Directors. “Dawn’s deep understanding for the unique needs and expectations of IFF’s customers and partners will be valuable to our Board and management team as we continue executing on our new long-term strategic and financial vision.”

“I have long admired IFF’s world-class portfolio, strong commitment to innovation and customer-centric approach and I am honored to join the Board as IFF becomes an even better partner for its diverse and global customer base,” said Willoughby. “I am pleased to partner with IFF’s Board and Executive Leadership Team to leverage the company’s industry-leading offering and unlock future growth for the benefit of all stakeholders.”

Willoughby served as executive vice president and chief operating officer of The Clorox Company until 2019. In this role, she oversaw the company’s five core global functions — Marketing, Sales, Product Supply, Research & Development and Information Technology — as well as the International Division and Burt's Bees®, Nutranext® and Renew Life® businesses. Prior to her time at Clorox, Willoughby spent nine years with The Procter & Gamble Company, where she held several sales management positions. Willoughby serves as a Director on the Boards of J.M. Smucker Company and TE Connectivity. She holds a bachelor’s degree in Sports Management from the University of Minnesota and a master’s degree in Business Administration from the University of California, Los Angeles Anderson School of Business.

Welcome to IFF

At IFF (NYSE: IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter, Facebook, Instagram, and LinkedIn.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Paula Heinkel
Head of Global Communications
332-877-5339
Media.request@iff.com

Michael Bender
Director, Investor Relations
212-708-7263
Investor.Relations@iff.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda Completes Acquisition of Nimbus Therapeutics’ TYK2 Program Subsidiary9.2.2023 00:30:00 CET | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that it has completed an acquisition of all shares of Nimbus Lakshmi, Inc. (“Lakshmi”) from Nimbus Therapeutics, LLC (“Nimbus”), on February 8, 2023 (EST), as set forth in the share purchase agreement, following clearance from the United States Federal Trade Commission and a satisfaction of other closing conditions. The agreement had been announced on December 13, 2022: “Takeda to Acquire 100% Ownership of Nimbus Therapeutics’ TYK2 Program Subsidiary”. Following the completion of this transaction, Takeda has now acquired TAK-279, formerly known at Nimbus as NDI-034858. With Phase 2b data to be presented in Q4 FY2022 and Phase 3 study in psoriasis expected to start in 2023, TAK-279 has the potential to demonstrate best-in-class efficacy, safety and convenience in psoriasis as well as multiple other immune-mediated diseases, including inflammatory bowel disease, psoriatic arthritis and systemic lupus erythematosus. This acquisition strengthens T

O-RAN ALLIANCE Events and Demos at MWC Barcelona Showcasing O-RAN Ecosystem Progress9.2.2023 00:24:00 CET | Press release

Join us for O-RAN ALLIANCE Ecosystem Briefing, February 28, 2023 at MWC Barcelona This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230208005994/en/ O-RAN ALLIANCE plans to hold its next industry event on Tuesday, February 28, 2023 from 15:30-16:30 CET at the Deutsche Telekom booth (Hall 3, Stand 3M31). The event will include: An update on O-RAN’s progress and future directions by Alex Jinsung Choi, Chair of the Board of O-RAN ALLIANCE and SVP Group Technology at Deutsche TelekomStefan Engel-Flechsig, O-RAN ALLIANCE COO Views on important areas supporting widespread adoption of open RAN, featuring leading operators from Asia, Europe and the Americas: Open RAN testing and integration – by Chih-Lin I, Chief Scientist from China Mobile and Co-chair of O-RAN Technical Steering Committee Open RAN security – by Claire Chauvin, Strategy Architecture and Standardization Director at Orange Open software for the RAN – by Rob Soni, VP RAN

IFF Reports Fourth Quarter and Full Year 2022 Results8.2.2023 22:31:00 CET | Press release

International Flavors & Fragrances Inc. (NYSE: IFF) reported financial results for the fourth quarter and full year ended December 31, 2022. Management Commentary “IFF delivered solid financial results in 2022 in what continues to be a challenging operating environment,” said IFF CEO Frank Clyburn. “Throughout the year our team successfully executed on what we could control – pricing, productivity and portfolio optimization – to generate strong sales growth, enhance profitability and reduce our debt. At the same time, we introduced a refreshed growth-focused strategy, that deepens our commitment to customers, prioritizes our highest-return businesses, and expands productivity to drive long-term profitable growth. We are confident that these are the right strategies to navigate near-term challenges – as we balance growth, profitability and cash flow generation – and deliver long-term value creation for our shareholders.” Fourth Quarter2022 Consolidated Financial Results Reported net sal

Global Partners Announce Innovations for Marine Managers to Help Our Oceans With Private Sector Support From Mary Kay Inc.8.2.2023 18:03:00 CET | Press release

Ocean conservation managers and practitioners, global experts, and high-level officials are convening for the Fifth International Marine Protected Area Congress (IMPAC5) from February 3-9 in Vancouver, Canada, to take a stand to protect the ocean. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230208005180/en/ MPAth, short for Marine Protected Area Tool Hub, is a free online resource for seascape stakeholders at every level. It uses the same problem-solving matrix honed by marine experts to guide users through a learning journey and help them address their most pressing challenges on sustainable livelihoods, financing, effectiveness, and climate change. (Credit: UN Environment Programme) IMPAC5 is known as the preeminent conference for the exchange of knowledge within the global community of marine conservation managers, practitioners, and decision makers. It provides the opportunity to highlight the latest science and share

Morgan Stanley Hosts First Global Demo Day for Startups in Inclusive Ventures Lab8.2.2023 16:23:00 CET | Press release

Morgan Stanley (NYSE: MS) today is hosting its first global in-person Demo Day, with 10 participating companies from the US and Europe, the Middle East and Africa (EMEA). The cohort companies, all founded by women, will pitch over 200 investors, as well as potential business partners and customers. Over the past five months, Morgan Stanley’s Inclusive Ventures Lab has supported its eighth cohort of technology-enabled startups in the post-seed to Series A funding round stage, offering an intensive accelerator program designed to provide a variety of mentorship opportunities and business-growth resources from across the Firm’s network. “We are on a mission to change the investing landscape for underrepresented founders. Through our accelerator program we are providing promising startups with much-needed capital, the broad resources of Morgan Stanley and access to investors,” said Selma Bueno, Managing Director and Global Head of the Inclusive Ventures Group. “Today’s Demo Day showcases i